Fractyl Health, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Fractyl Health, Inc. (GUTS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $484.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-10
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$290.00K.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $774.00K, a 16.39% increase year-over-year.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$68.00K, a 105.18% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$2.35M.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.25M, a 202.32% decline from fiscal 2024.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.20M.
- Fractyl Health, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$331.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $484.00K 10-Q · filed 2026-08-10 | $416.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.94M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $774.00K 10-Q · filed 2026-05-12 | $706.00K derived: sum of 2 quarters · filed 2026-05-12 | -$1.65M derived: sum of 3 quarters · filed 2026-05-12 | -$2.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$2.42M derived: sum of 2 quarters · filed 2026-03-24 | -$2.91M derived: sum of 3 quarters · filed 2026-08-10 | -$2.25M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.85M derived: sum of 2 quarters · filed 2026-08-10 | -$2.18M 10-Q · filed 2025-11-12 | -$868.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $171.00K 10-Q · filed 2026-08-10 | $1.48M derived: sum of 3 quarters · filed 2026-08-10 | $682.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $665.00K 10-Q · filed 2026-05-12 | $1.98M derived: sum of 2 quarters · filed 2026-05-12 | $1.18M derived: sum of 3 quarters · filed 2026-05-12 | $2.26M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $511.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.60M derived: sum of 3 quarters · filed 2026-03-24 | $2.20M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $286.00K derived: sum of 2 quarters · filed 2025-11-12 | $885.00K 10-Q · filed 2025-11-12 | $1.02M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.69M 10-Q · filed 2025-08-12 | $1.82M derived: sum of 3 quarters · filed 2025-08-12 | $2.12M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $599.00K 10-Q · filed 2025-05-13 | $732.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.04M derived: sum of 3 quarters · filed 2025-05-13 | $979.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $438.00K derived: sum of 2 quarters · filed 2025-03-03 | $380.00K derived: sum of 3 quarters · filed 2025-03-03 | -$331.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $247.00K derived: sum of 2 quarters · filed 2024-11-12 | -$464.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$769.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$711.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |